Logo of ProBio

ProBio

ProBio is a global Contract Development and Manufacturing Organization (CDMO) enabling biotech and pharmaceutical companies to advance the development and manufacturing of next generation therapies. With deep expertise in cell and gene therapy, ProBio delivers integrated, end to end solutions across mRNA, plasmid DNA, viral vectors, and in vivo CAR T therapies.ProBio's scalable, GMP compliant platforms support partners from early development through commercial manufacturing, helping accelerate timelines and de risk complex programs. Through a collaborative, risk sharing model, ProBio also offers flexible options for licensing and co development, empowering partners to efficiently navigate the scientific and regulatory challenges of advanced therapeutics.

Content by ProBio

3D illustration of an antibody-drug conjugate attacking a cancer cell, with a red and teal antibody binding to the tumor cell surface as it breaks apart.
| 2 min read
The modern exterior of ProBio's multi-story biologics manufacturing facility in Nanjing, China, featuring a large glass facade and a sleek, industrial design.
| 3 min read
Close-up of an automated pharmaceutical fill-finish manufacturing line processing numerous glass vials on a sterile metal conveyor system.
| 3 min read
Illustration of DNA and cells, symbolizing in vivo CAR T therapies.
| 6 min read
ProBio logo
| 3 min read
Abstract digital illustration of a researcher in a lab coat interacting with floating, futuristic medical data interfaces, including DNA strands, brain icons, pills, and molecular structures, all tinted in a bright green hue.
| 2 min read
3D illustration showing a close-up of a large blue T-cell with yellow and orange receptors on its surface, surrounded by several smaller, similar cells floating against a light blue background.
| 3 min read
3D rendering of a microscopic virus particle, shown as a textured, translucent sphere with long, spike-like protrusions extending outwards, set against a bright, glowing turquoise background.
| 2 min read
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gloved hand holding a multiwell cell culture plate under a fluorescence microscope for spheroid analysis.
Using confocal live-cell imaging to characterize immune-mediated cytotoxicity over time.
Fluorescence microscopy image of cells displaying green and red fluorescent signals.
Using confocal live-cell imaging to assess treatment effects in spheroids, organoids, and co-cultures.
3D illustration of Y-shaped antibody molecules floating against a soft blue background, with a detailed antibody structure in the foreground.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.